Innovating.works Conecta tu I+D

Showing 1 to 20 of 60 results

RADAR-CNS: Remote Assessment of Disease and Relapse in Central Nervous System Disorders GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un H2020 H2020-JTI-IMI2-2015-03-two-stage Background: Long term conditions require monitoring of patients, traditionally conducted in the clinic, to monitor treatment effects, advers...
2016-03-31 - 2022-03-31 | Financiado

SVDs-at-target: Small vessel diseases in a mechanistic perspective Targets for Intervention Affected pathways and m... GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un H2020 H2020-PHC-2014-2015 Stroke and dementia rank among the most pressing health issues in Europe. Cerebral small vessel diseases (SVDs) have emerged as a central li...
2015-12-15 - 2021-12-31 | Financiado

RELENT: RELapses prevENTion in chronic autoimmune disease common mechanisms and co morbidities GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un H2020 H2020-PHC-2014-2015 RELENT is multidisciplinary group of scientists and clinical investigators whose goal is to develop individualized treatment for chronic aut...
2015-12-09 - 2020-04-30 | Financiado

SENSE-Cog: Ears Eyes and Mind The SENSE Cog Project to improve mental well being for elderly Europeans with... GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un H2020 H2020-PHC-2014-2015 Mental, cognitive, vision and hearing health problems in elderly people are amongst the top 10 public health challenges in Europe. They freq...
2015-12-09 - 2022-06-30 | Financiado

HemAcure: Application of combined gene and cell therapy within an implantable therapeutic device for the treat... GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un H2020 H2020-PHC-2014-2015 The main objective of the HemAcure project is to develop and refine the tools and technologies for a novel ex vivo prepared cell based thera...
2015-12-09 - 2018-10-31 | Financiado

FOLSMART: Folate Target Nanodevices To Activated Macrophages For Rheumatoid Arthritis GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un H2020 H2020-NMP-2014-2015 FOLSMART will bring to phase I clinical trials novel folate-based nanodevices (FBN) for the treatment of rheumatoid arthritis (RA). These na...
2015-11-25 - 2020-12-31 | Financiado

DIACAT: Diamond materials for the photocatalytic conversion of CO2 to fine chemicals and fuels using visible... GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un H2020 H2020-FETOPEN-2014-2015 In DIACAT we propose the development of a completely new technology for the direct photocatalytic conversion of CO2 into fine chemicals and...
2015-05-26 - 2019-12-31 | Financiado

PRECIOUS: PREvention of Complications to Improve OUtcome in elderly patients with acute Stroke GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un H2020 H2020-PHC-2014-2015 Every year, 1.3 million Europeans have a stroke and one million ultimately die of stroke. One third of stroke patients remain dependent on t...
2015-04-07 - 2022-11-30 | Financiado

TREGeneration: Repair of tissue and organ damage in refractory chronic graft versus host disease after hematopoieti... GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un H2020 H2020-PHC-2014-2015 Our proposal encompasses parallel clinical trials addressing the feasibility and the effectiveness of donor-derived regulatory T cells (Treg...
2014-12-01 - 2021-12-31 | Financiado

CANCER-ID: Cancer treatment and monitoring through identification of circulating tumour cells and tumour relate... GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un FP6 Blood-based biomarkers such as Circulating Tumor Cells (CTCs), circulating free tumor DNA (cfDNA) and microRNAs (miRNAs) have the potential...
2015-01-01 - 2019-12-31 | Financiado

EUC²LID: European Lead Factory GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un FP6 The European Lead Factory concept proposed by the EUC2LID Consortium relates to the discovery of novel small molecule candidates to serve as...
2013-01-01 - 2018-05-31 | Financiado

EU-AIMS: European Autism Interventions - A Multicentre Study for Developing New Medications GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un FP6 Despite dramatic advances in molecular and imaging technologies, there are currently no effective pharmacological treatments for the core sy...
2012-04-01 - 2018-03-31 | Financiado

ONCOTRACK: OncoTrack - Methods for systematic next generation oncology biomarker development GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un FP6 We propose here an exhaustive analysis of the genome, exome, methylome and transcriptome of primary tumours and metastases from patients wit...
2011-01-01 - 2016-12-31 | Financiado

NEWMEDS: Novel Methods leading to New Medications in Depression and Schizophrenia GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un FP6 Despite dramatic advances in molecular and imaging technologies and nearly 1 5,000 articles on schizophrenia and depression (S&D) there are...
2009-09-01 - 2015-02-28 | Financiado

NEWMEDS: Novel Methods leading to New Medications in Depression and Schizophrenia GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un FP7 Despite dramatic advances in molecular and imaging technologies and nearly 1 5,000 articles on schizophrenia and depression (S&D) there are...
Financiado

CARDIORISK: The mechanisms of cardiovascular risks after low radiation doses GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un FP7 Recent epidemiologic evidence suggests that moderate and low radiation doses to the heart may result in a moderate, but significant increase...
Financiado

EU-CERT-ICD: Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverte... GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un FP7 An estimated 500.000 sudden cardiac deaths (SCD) occur each year in the European Union. Patients at risk for SCD may benefit from prophylact...
Financiado

OSPI-EUROPE: Optimizing suicide prevention programs and their implementation in Europe GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un FP7 Suicide is a serious public health problem in the EU calling for effective interventions. The aim of this project is to provide EU member st...
Financiado

ESGI: European Sequencing and Genotyping Infrastructure GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un FP7 The objective of this project is the integration of world class high-throughput sequencing and genotyping facilities that will provide seque...
Financiado

EPIMIRNA: MicroRNAs in the Pathogenesis Treatment and Prevention of Epilepsy GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un FP7 Epilepsy is a major burden for patients and health systems worldwide. It is a common chronic neurological disorder affecting people of all a...
Financiado

GABO:mi